tirzepatide launch Eli Lilly (LLY) Gets Nod to Weight-Loss Drug Mounjaro in Hong Kong Tirzepatide Market Forecast Tirzepatide drug

Phase 3 will also involve the SURPASS 2 study, which will be a comparison with semaglutide (Ozempic), and it is expected to finish before 2022

L-Carnitine shines in exercise performance and heart health, with studies suggesting it can reduce fatigue and improve cardiovascular markers

Adderall and other stimulants are first-line and the most effective treatment for ADHD

The paper is currently an unedited Article in Press, meaning it may still undergo final editing before final publication

Discontinuing Ozempic requires careful medical supervision to prevent deterioration in blood glucose control and manage potential changes in weight and appetite